Himadri Speciality Chemical Ltd.
NSE: HSCLHimadri Speciality Chemical Ltd.: A 30-second snapshot
Himadri Speciality Chemicals (HSCL) trades at ₹749.65, up 46.33% over 12 months and 23.52% over 3 months, and sits 8.52% below its 52-week high with price above both the 50-DMA (₹672.02) and 200-DMA (₹528.05). Trailing PE is 48.45 (forward PE 37.37) against a 16.07% profit margin and 28% five-year revenue growth, with recent news centered on a record Q1 profit, a ₹240 crore technology investment, and expansion into lithium iron phosphate (LFP) battery materials. Within the Chemicals sector the stock ranks 3rd of 6 peers on qualityScore (57) and 4th of 6 on PE.
P/E
48.5
Forward P/E
37.4
ROE
—
Debt / Equity
16.17
Profit Margin
+16.1%
Div. Yield
+0.1%
5Y ROE > 15%
1/5
5Y FCF > 0
2/5
Quality
56/100
News
6 headlines · 3 positive · 0 negative
Himadri Speciality Doubles Down on Lithium Iron Phosphate as Q1 Profit Hits a Record - Moneylife
Moneylife
Himadri Speciality Chemicals Invests ₹240 Crore in New Tech - Whalesbook
Whalesbook
Himadri Partner Siconna Secures $31 Million Grant for High-Tech Battery Material Plant - Sahi
Sahi
Stock Radar: Himadri Speciality stock hits fresh record high in July 2026; time to buy? - economictimes.com
economictimes.com
Himadri Speciality Chemical Ltd. Revenue Breakdown – NSE:HSCL - TradingView
TradingView
Recent context
- ·Moneylife (2026-07-22) reported Himadri's Q1 profit hit a record alongside continued focus on lithium iron phosphate (LFP) capacity.
- ·Whalesbook (2026-07-20) reported a ₹240 crore investment in new technology.
- ·Sahi (2026-07-07) reported that partner Siconna secured a $31 million grant for a battery material plant; Economic Times (2026-07-21) noted the stock hit a fresh record high in July 2026.
Strengths
- +Five-year revenue growth of 28% and earnings growth of 24.7%, with a 16.07% profit margin.
- +News sentiment skews positive (3 positive, 3 neutral, 0 negative of 6 recent articles), including reports of a record Q1 profit and a ₹240 crore technology investment.
- +Price trades above both the 50-DMA and 200-DMA, up 46.33% over 12 months, with drawdown from the 52-week high limited to 8.52%.
- +Strategic expansion into LFP battery materials, including partner Siconna securing a $31 million grant for a battery material plant.
Weaknesses
- −Reported debt-to-equity of 16.17 is far above typical Chemicals-sector levels and, combined with a flat debt trend, is large enough relative to the rest of the profile to merit independent verification as a possible data/unit anomaly.
- −ROE exceeded 15% in only 1 of the tracked historical years and FCF was positive in only 2 years, giving a consistencyScore of 42/100 against a trailing PE of 48.45.
- −Analyst coverage is limited to a single analyst (rating 3 on a 1-5 scale), leaving thin independent scrutiny of the current growth narrative.
- −Price sits 11.6% above the 50-DMA and 42.0% above the 200-DMA after a rapid 3-month advance, and the stock's PE ranks 4th of 6 Chemicals peers (three peers cheaper on PE).
Open questions
- ?How does the reported debt-to-equity of 16.17 reconcile with a flat debt trend and stable margins — is this figure a genuine leverage measure or worth independently checking against source filings?
- ?Does the recent price and news momentum around record Q1 profit and LFP capacity investment reflect a structural shift in earnings quality, or does the weak multi-year ROE/FCF persistence (consistencyScore 42/100) suggest it's too early to tell?
- ?With only one analyst providing coverage, what independent data points could be used to corroborate or challenge the growth narrative embedded in the current valuation?
- ?How does the gap between trailing PE (48.45) and forward PE (37.37) compare with the company's five-year revenue growth of 28% and its stated capacity-expansion plans?
Peer comparison: Chemicals
Ranks 3 of 6 on quality| Symbol | Name | P/E | ROE | Quality |
|---|---|---|---|---|
| HSCL | Himadri Speciality Chemical Ltd.You're viewing | 48.5 | — | 57 |
| Industry avg | across 5 peers | 53.2 | +22.4% | 47 |
| PIDILITIND | Pidilite Industries Ltd. | 68.0 | +23.5% | 66 |
| SOLARINDS | Solar Industries India Ltd. | 97.2 | +31.2% | 61 |
| SRF | SRF Ltd. | 36.2 | — | 56 |
| COROMANDEL | Coromandel International Ltd. | 32.9 | — | 30 |
| PIIND | PI Industries Ltd. | 31.6 | +12.3% | 23 |
Technical state
Current price
₹749.65
SMA 50
₹672.02
SMA 200
₹528.05
RSI (14)
58.1 (neutral)
From 52w high
-8.5%
1Y return
+46.3%
3M return
+23.5%
50-DMA
Above
200-DMA
Above
Algorithmic support levels
Algorithmic resistance levels
Risk flags
- highReported debt-to-equity of 16.17 is an order of magnitude above typical Chemicals-sector levels and sits alongside a flat debt trend, a 16.07% profit margin, and 28% five-year revenue growth; the magnitude is inconsistent enough with the rest of the profile that it warrants verification as a possible data or unit-reporting anomaly rather than being read as confirmed leverage stress.
- mediumROE exceeded 15% in only 1 of the tracked historical years and free cash flow was positive in only 2 years, producing a consistencyScore of 42 of 100, while the stock carries a trailing PE of 48.45 (forward PE 37.37) — historical quality persistence trails what the current valuation embeds.
- lowAnalyst coverage is limited to a single analyst (mean rating 3 on a 1-5 scale, lower = more constructive), leaving minimal independent third-party scrutiny of the growth narrative behind the stock's 46.33% one-year price gain.
- lowPrice of ₹749.65 sits 11.6% above the 50-DMA (₹672.02) and 42.0% above the 200-DMA (₹528.05) after a 23.52% three-month advance; PE of 48.45 ranks 4th of 6 Chemicals peers by valuation (three peers cheaper on PE).
Cross-section contradictions
- Price is up 46.33% over 12 months and news flow is uniformly non-negative (3 positive, 3 neutral, 0 negative of 6 articles) framing a record Q1 profit and large capacity investments, yet longer-run quality persistence is weak — ROE cleared 15% in only 1 tracked year and FCF was positive in only 2 years (consistencyScore 42/100) — with just one analyst covering the stock to independently corroborate the narrative.
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 11 Aug 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 30 Jul 2026 · rotates through NIFTY 500 every ~5 days